News

New test for STI in a bid to stop superbug

An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment …

Continue Reading

Treat gonorrhoea with Resistance Guided Therapy

Updated treatment guidelines and the availability of the ResistancePlus® GC test for Neisseria gonorrhoeae from SpeeDx, are making it possible …

Continue Reading

SpeeDx Increase European Distribution Network

SpeeDx announced signing two new distribution partners, creating comprehensive access for customers to market-leading SpeeDx ResistancePlus® and PlexPCR® tests across …

Continue Reading

Gonorrhoea guidelines call for ciprofloxacin susceptibility testing

The British Association for Sexual Health and HIV (BASHH) have published new guidelines for the management of gonorrhoea infections with …

Continue Reading

Two new cases of resistant gonorrhoea diagnosed in the UK

Public Health England (PHE) is investigating two cases of extensively drug resistant (XDR) gonorrhoea recently diagnosed in the U.K. XDR …

Continue Reading

ResistancePlus® GC receives CE-IVD mark

SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually …

Continue Reading

Johns Hopkins raising awareness of Mycoplasma genitalium resistance test for reproductive health

Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness …

Continue Reading

SpeeDx broaden European Distribution Network

SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and …

Continue Reading

Draft BASHH gonorrhoea guidelines recommend ciprofloxacin susceptibility testing

Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. …

Continue Reading

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG

SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus MG. “This test is an …

Continue Reading